Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Injection lipolysis effectively reduces small fat deposits and should be done with care and proper patient selection.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.

Re-evaluating minoxidil, reducing sodium intake, and addressing arteriolar hypertrophy can improve hypertension management.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

AI is revolutionizing healthcare by improving diagnosis, treatment, and monitoring, but still needs close supervision.

Nano-Pulse Stimulation™ Therapy is more effective and less damaging than cryoablation for treating melanoma tumors in mice.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Animal models, especially mice, are essential for advancing hair loss research and treatment.

Hair testing is a reliable method for detecting workplace drug use when done with proper sample preparation and confirmation.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.

Up to half of women by age 50 experience significant hair loss, with various types and treatments available.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

A mix of tocopherol acetate and L-menthol helps grow hair better than using them separately or using minoxidil.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Home-use cosmetic laser and light devices show modest results for hair removal and acne treatment, but more research is needed for confirmation.

Stem cell therapies show promise for treating various diseases but face challenges in clinical use and require better monitoring techniques.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

New 5% minoxidil foam effectively promotes hair growth and is safe for use.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

Measuring reproductive hormones in brown bear hair could help identify their sex and reproductive state, but better collection methods or lab techniques are needed.